PharmaCyte Biotech, Inc. (PMCB)
NASDAQ
Closed
Sep 21, 2026
Day's Range
0.440152 wk Range
0.3339Overview - PMCB - PharmaCyte Biotech, Inc.
Key Statistics
Valuation
Enterprise Value
-30.71M
P/E (Trailing)
‪14.00‬
P/E (Forward)
‪-1.16‬
PEG Ratio
‪-1.16‬
Price / Book
‪0.14‬
EV / EBITDA
‪-3.79‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-6.50%‬
Return on Equity
‪-44.72%‬
Ownership
Shares Outstanding
10.73M
Float
10.06M
Short % of Shares Outstanding
‪2.04%‬
Held by Insiders
‪5.74%‬
Held by Institutions
‪7.10%‬
Price stats
Beta
‪0.66‬
50-Day Avg
‪0.5903‬
200-Day Avg
‪0.7310‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PMCB - PharmaCyte Biotech, Inc.
Peers - PMCB - PharmaCyte Biotech, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- PMCBNASDAQPharmaCyte Biotech, Inc.4.74MMarket Cap-135.13%52-week change14.00P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQArgenx SE61.58BMarket Cap+25.27%52-week change37.92P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.32.05BMarket Cap-91.57%52-week change41.68P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE24.13BMarket Cap-2.77%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S15.57BMarket Cap+17.02%52-week change18.34P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.02BMarket Cap+22.62%52-week change-17.62P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.12.37BMarket Cap+15.64%52-week change172.81P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - PMCB - PharmaCyte Biotech, Inc.
About
PharmaCyte Biotech, Inc. is a clinical-stage biotechnology company focused on developing cellular therapies for cancer and diabetes. Its core platform is Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology designed to support therapies for difficult-to-treat conditions, including inoperable…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
